Dermal Cell News Volume 10.00 | Jan 8 2024

    0
    42








    2024-01-08 | DCN 10.01


    Dermal Cell News by STEMCELL Technologies
    Vol. 10.00 – 8 January, 2024
    TOP STORY

    A TCF4-Dependent Gene Regulatory Network Confers Resistance to Immunotherapy in Melanoma

    Targeting TCF4 genetically or pharmacologically, using a bromodomain inhibitor, increased immunogenicity and sensitivity of mesenchymal-like cells to immune checkpoint blockade and targeted therapy.
    [Cell]

    Full ArticleGraphical Abstract
    High-quality equipment, high-quality results. Click to explore.
    PUBLICATIONSRanked by the impact factor of the journal

    Bionic Artificial Skin with a Fully Implantable Wireless Tactile Sensory System for Wound Healing and Restoring Skin Tactile Function

    Scientists introduced a fully-implantable wireless-powered tactile sensory system embedded in artificial skin, with stable operation, to restore permanently damaged tactile function and promote wound healing for regenerating severely damaged skin.
    [Nature Communications]

    Full Article

    Apoptosis Recognition Receptors Regulate Skin Tissue Repair in Mice

    Investigators used single-cell RNA sequencing to provide a map of the cellular dynamics during early inflammation in mouse skin wounds.
    [eLife]

    Full Article

    Development of Human-Derived Photocrosslinkable Gelatin Hydrogels for Tissue Engineering

    Scientists developed glycidyl methacrylate-modified human-derived gelatin hydrogels for use in tissue engineering applications.
    [Biomacromolecules]

    AbstractGraphical Abstract

    Biological and Mechanical Influence of Three-Dimensional Microenvironment Formed in Microwell on Multicellular Spheroids Composed of Heterogeneous Hair Follicle Stem Cells

    Researchers cultured hair follicle (HF)-derived cells, which were mainly composed of HF stem cells, in the form of 3D spheroids using a microwell array, and investigated the influences of microwell depth on HF spheroid formation and biological conditions.
    [Scientific Reports]

    Full Article

    Human Keratin Matrices Promote Wound Healing by Modulating Skin Cell Expression of Cytokines and Growth Factors

    The authors developed a novel biomaterial, the human keratin matrix, which was characterized, and tested in vitro and in vivo.
    [Wound Repair And Regeneration]

    Full Article

    Inhibition of Integrin-Associated Kinases FAK and ILK on the In Vitro Model of Skin Wound Healing

    Since the connection between cells and matrix was provided by transmembrane integrin receptors, scientists aimed at studying the dynamics of signaling pathways associated with integrins on an in vitro model of wound healing using human skin fibroblasts.
    [Applied Biochemistry And Biotechnology]

    Abstract

    In Situ Production and Secretion of Proteins Endow Therapeutic Benefit against Psoriasiform Dermatitis and Melanoma

    Signal peptides-engineered etanercept/TNF-α inhibitor proteins demonstrated therapeutic efficacy in an imiquimod-induced psoriasis model by reducing hyperkeratosis and inflammation.
    [Proceedings Of The National Academy Of Sciences Of The United States Of America]

    Full Article

    Role of PLK1/NUMB/NOTCH in Epithelial-Mesenchymal Transition in Human Melanoma

    Using multiple PLK1-modulated melanoma cell lines, investigators found that PLK1 was involved in the regulation of cell migration, invasion, and epithelial-mesenchymal transition via its kinase activity and NOTCH activation.
    [NPJ Precision Oncology]

    Full Article
    Request a free wallchart for a quick reference on growing organoids from stem cells.
    REVIEWS

    Melanoma and Microbiota: Current Understanding and Future Directions

    The authors review the state of the microbiota field in the context of melanoma, the recent breakthroughs in defining microbial modes of action, and how to modulate the microbiota to enhance response to cancer immunotherapy.
    [Cancer Cell]

    Abstract
    INDUSTRY AND POLICY NEWS

    Opdualag Licensed for Patients with Advanced Melanoma

    The Medicines and Healthcare products Regulatory Agency has approved the advanced melanoma medicine Opdualag (nivolumab-relatlimab) for patients from the age of twelve.
    [Medicines and Healthcare Products Regulatory Agency]

    Press Release
    FEATURED EVENT

    Tandem Meetings Transplantation & Cellular Therapy Meetings of ASTCT® and CIBMTR®

    February 21 – 24, 2024
    San Antonio, Texas, United States

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Scientist – Cancer Research Cluster

    Cedars-Sinai – Los Angeles, California, United States

    Postdoctoral Fellows – Immunology

    Northwestern University – Chicago, Illinois, United States

    PhD Positions – Tissue Regeneration and Cancer Immunotherapy

    Albert-Ludwigs-University Freiburg – Freiburg im Breisgau, Germany

    Bioinformatician – Skin Cancer Research

    Helmholtz Association of German Research Centres – Heidelberg, Germany

    Animal Technician – Experimental Therapeutics

    BC Cancer – Vancouver, British Columbia, Canada

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2